In this highly interactive event, we will take Alzheimer’s drug discovery as a biomarker case study.
This is not solely an ‘Alzheimer symposium’: many of the emerging insights and concepts of this research will apply to other diseases as well.
Experts in Alzheimer’s disease and biomarkers from the US as well as the Biomarker Bay consortium from the Netherlands will be present.
They will share their new data and discuss emerging trends and novel insights.
Join us and dive into this exciting field to connect with your colleagues from around the world!

The event will start at 4.00 pm, and at 6 pm there will be an opportunity for networking.